Pharmacological approaches for the treatment of strabismus

Drugs of the Future

Volumn 30, Issue 3, 2005, Pages 319-327

  McLoon, Linda K ^a   Christiansen, Stephen P ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BOTULINUM TOXIN A; CARDIOTROPHIN 1; CD19 ANTIBODY; CD19 ANTIGEN; CD22 ANTIBODY; CD22 ANTIGEN; CD25 ANTIBODY; DIPHTHERIA TOXIN; DR ITOX; GROWTH FACTOR; HYBRID PROTEIN; IMMUNOTOXIN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 35; MONOCLONAL ANTIBODY 73; MYOGENIC GROWTH FACTOR; NERVE GROWTH FACTOR; NICOTINIC RECEPTOR; RECEPTOR ANTIBODY; RICIN; RICIN A; SAPORIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFERRIN; UNCLASSIFIED DRUG;

AMBLYOPIA; BRAIN CANCER; CLINICAL TRIAL; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; HUMAN; MUSCLE FORCE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; REVIEW; STRABISMUS; STRABISMUS SURGERY; TREATMENT OUTCOME;

EID: 18844413276     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2005.030.03.891455     Document Type: Review

References (64)

1. Friedman, Z., Neumann, E., Hyams, S.W., Peleg, B. Ophthalmic screening of 38,000 children, age 1 to 2 1/2 years, in child welfare clinics. J Pediatr Ophthalmol Strabismus 1980, 17: 261-7.
2. Graham, P.A. Epidemiology of strabismus. Br J Ophthalmol 1974, 5: 224-31.
3. Stidwell, D. Epidemiology of strabismus. Ophthal Physiol Opt 1997, 17: 536-9.
4. Bremer, D.L., Palmer, E.A., Fellows, R.R., Baker, J.D., Hardy, R.J., Tung, B., Rogers, G.L. Strabismus in premature infants in the first year of life. Arch Ophthalmol 1998, 116: 329-33.
5. Holmstrom, G., el Azazi, M., Kugelberg, U. Ophthalmological follow up of preterm infants: A population based, prospective study of visual acuity and strabismus. Br J Ophthalmol 1999, 83: 143-50.
6. Charles, S.J., Moore, A.T. Results of surgery for infantile esotropia in normal and neurologically impaired infants. Eye 1992, 6: 603-6.
7. Attebo, K., Mitchell, P., Cumming, R., Smith, W., Jolly, N, Sparkes, R. Prevalence and causes of amblyopia in an adult population. Ophthalmology 1998, 105: 54-159.
8. Fenstemaker, S.B., Kiorpes, L., Movshon, J.A. Effects of experimental strabismus on the architecture of macaque monkey striate cortex. J. Comp Neurol 2001, 438: 300-17.
9. Kind, P.C., Mitchell, D.D., Ahmed, B., Blakemore, C., Bonhoeffer, T., Sengpiel, F. Correlated binocular activity guides recovery from monocular deprivation. Nature 2002, 416: 430-3.
10. Keenan, J.M., Willshaw, H.E. Outcome of strabismus surgery in congenital esotropia. Br J Ophthalmol 1992, 76: 342-5.
11. Birch, E.E., Fawcett, S., Stager, D.R. Why does early surgical alignment improve stereoacuity outcomes in infant esotropia? J AAPOS 2000, 4: 10-4.
12. Ruiz, M.F., Alvarez, M.T., Sanchez-Garrido, C.M., Hernaez, J.M., Rodriguez, J.M. Surgery and botulinum toxin in congenital esotropia. Can J Ophthalmol 2004, 39: 639-49.
13. Rosenbaum, A.L., Egbert, J.E., Keogan, T., Wheeler, N., Wang, C., Buzard, K. Length-tension properties of extraocular muscles in patients with esotropia and intermittent exotropia. Am J Ophthalmol 1994, 117: 791-9.
14. Christiansen, S.P., Soulby, M.E., Seifern, E.E. Effect of antagonist weakening on developed tension in cat extraocular muscle. Invest Ophthalmol Vis Sci 1995, 36: 2547-50.
15. Demer, J.L., Oh, S.Y., Poukens, V. Evidence for active control of rectus extraocular muscle pulleys. Invest Ophthalmol Vis Sci 2000, 41: 1280-90.
16. Scott, A.B., Rosenbaum, A., Collin, C. Pharmacological weakening of extraocular muscles. Invest Ophthalmol 1973, 12: 924-7.
17. Scott, A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980, 87: 1044-9.
18. Elston, J.S., Lee, J.P., Powell, C.M., Hogg, C., Clark, P. Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol 1985, 69: 718-24.
19. Ing, M.R. Botulinum alignment for congenital esotropia. Ophthalmology 1993, 100: 318-22.
20. Ing, M.R. Botulinum toxin treatment of infantile esotropia In children. Arch Ophthalmol 1998, 116: 833.
21. Spencer, R.F., Tucker, M.G., Choi, R.Y., McNeer, K.W. Botulinum toxin management of childhood intermittent exotropia. Ophthalmology 1997, 104: 1762-7.
22. McNeer, K.W., Tucker, M.G., Spencer, R.F. Botulinum toxin management in essential infantile esotropia in children. Arch Ophthalmol 1997, 115: 1411-8.
23. Rayner, S.A., Hollick, E.J., Lee, J.P. Botulinum toxin in childhood strabismus. Strabismus 1999, 7: 103-11.
24. Lawson, J.M.M., Kousoulides, L., Lee, J.P. Long term results of botulinum toxin in consecutive and secondary exotropia: Outcome in patients initially treated with botulinum toxin. J AAPOS 1998, 2: 195-200.
25. Hubel, D.H., Wiesel, T.N. Single-cell responses in striate cortex of kittens deprived of vision in one eye. J Neurophysiol 1963, 26: 1003-17.
26. Hubel, D.H., Wiesel, T.N. Binocular interaction in striate cortex of kittens reared with artificial squint. J Neurophysiol 1965, 28: 1041-59.
27. Trachtenberg, J.T., Stryker, M.P. Rapid anatomical plasticity of horizontal connections in the developing visual cortex. J Neurosci 2001, 21: 3476-82.
28. Innocenti, G.M., Frost, D.O., Illes, J. Maturation of visual callosal connections in visually deprived kittens: A challenging critical period. J Neurosci 1985, 5: 255-67.
29. Tusa, R.J., Mustari, M.J., Burrows, A.F., Fuchs, A.F. Gaze-stabilizing deficits and latent nystagmus in monkeys with brief, early-onset visual deprivation: Eye movement recordings. J Neurophysiol 2001, 86: 651-61.
30. Laske, D.W., Oldfield, E., DeVroom, H., Sung, C., Dedrick, R., Simon, T., Colandrea, J., Copeland, C., Katz, D., Greenfield, L., Groves, E., Houston, L., Youle, R.J. Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery 1997, 41: 1039-49.
31. Laske, D.W., Youle, R.J., Oldfield, E. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 1997, 3: 1362-8.
32. Oldfield, E.H., Youle, R.J. Immunotoxins for brain tumor therapy. Curr Top Microbiol Immunol 1998, 234: 97-114.
33. Schindler, J., Sausville, E., Messmann, R., Uhr, J.W., Vitetta, E.S. The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: A retrospective analysis of patients in five clinical trials. Clin Cancer Res 2001, 7: 255-8.
34. Schnell, R., Borchmann, P., Staak, J.O., Schindler, J., Gehetie, V., Vitetta, E.S., Engert, A. Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol 2003, 14: 729-36.
35. Vallera, D.A., Ash, R., Zanjani, E., Kersey, J., LeBien, T., Beverley, P., Neville, D., Youle, R.J. Anti-T-cell reagents for human bone marrow transplantation: Ricin linked to three monoclonal antibodies. Science 1983, 222: 512-5.
36. Filipovich, A.H., Vallera, D., Youle, R.J., Quinones, R., Neville, D., Kersey, J.H. Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease. Lancet 1984, 1: 469-72.
37. Hott, J.S., Dalakas, M.C., Sung, C., Hallett, M., Youle, R.J. Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm. Neurology 1998, 50: 485-91.
38. Christiansen, S.P., Sandnas, A., Prill, R., Youle, R.J., McLoon, L.K. Acute effects of the skeletal muscle-specific immunotoxin, ricin-mAb35, on extraocular muscles of rabbits. Invest Ophthalmol Vis Sci 2000, 41: 3402-9.
39. Christiansen, S.P., Peterson, D., To, T., Youle, R., McLoon, L.K. Long-term effects of the skeletal muscle-specific immunotoxin, ricin-mAb35, on extraocular muscles of rabbits: Potential treatment for strabismus. Invest Ophthalmol Vis Sci 2002, 43: 679-85.
40. Campos, E.G., Schiavi, C., Bolognesi, A., Bellusci, C., Lubelli, C., Duca, A., Polito, L., Poulas, K., Tzartos, S.J., Stirpe, F. Selective lesions of rabbit extraocular muscles injected with the anti-AchR immunotoxin saporin-mAb73. Curr Eye Res 2002, 24: 58-65.
41. Harrison, A., Skladzien, S., Christiansen, S.P., McLoon, L.K. Acute effects of the skeletal muscle-specific immunotoxin, ricin-mAb35, on orbicularis oculi muscle after eyelid injections in rabbits. Ophthal Plast Reconstr Surg 2004, 20: 312-6.
42. Falkenberg, J.H., Iaizzo, P.A., McLoon, L.K. In situ physiological assessment of muscle strength after direct injection of doxorubicin into rabbit sternocleidomastoid muscle. Muscle Nerve 2002, 25: 735-41.
43. Christiansen, S.P., Becker, B.A., Iaizzo, P.A., McLoon, L.K. Extraocular muscle force generation after ricin-mAb35 injection: Implications for strabismus treatment. J AAPOS 2003, 7: 1-6.
44. Christiansen, S.P., Becker, B., McLoon, L.K. Long-term effects of ricin-mAb35 injection on extraocular muscle force generation in rabbits. Invest Ophthalmol Vis Sci 2003, 44: 3125.
45. Adams, G.R., McCue, S.A. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998, 84: 1716-22.
46. Musaro, A., McCullagh, K., Naya, F., Olson, E.N., Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin. Nature 1999, 400: 581-5.
47. Barton-Davis, E.R., Shoturma, D.I., Musaro, A., Rosenthal, N., Sweeney, H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998, 95: 15603-7.
48. Lynch, G.S., Cuffe, S.A., Plant, D.R., Gregorevic, P. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromusc Disord 2001, 11: 260-8.
49. Barton, E.R., Morris, L., Musaro, A., Rosenthal, N., Sweeney, H.L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002, 157: 137-47.
50. Domenici, L., Parisi, V., Maffei, L. Exogenous supply of nerve growth factor prevents the effects of strabismus in the rat. Neuroscience 1992, 51: 19-24.
51. Olwin, B.B., Hauschka, S.D. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture. J Cell Biol 1988, 107: 761-9.
52. Krishan, K., Dhoot, G.K. Changes in some troponin and insulin-like growth factor mRNA in regenerating and denervated skeletal muscles. J Muscle Res Cell Motil 1996, 17: 513-21.
53. McLoon, L.K., Peters, E., Wirtschafter, J.D. Adult extraocular muscles express HSPG, Syndecan and growth factor receptor molecules that normally are down regulated in adult skeletal muscle. Invest Ophthalmol Vis Sci 1999, 40: S408.
54. Fischer, M.D., Gorospe, J.R., Felder, E., Bogdanovich, S., Pedrosa-Domellof, F., Ahima, R.S., Rubinstein, N.A., Hoffman, E.P., Khurana, T.S. Expression profiling reveals metabolic and structural components of extraocular muscles. Physiol Genomics 2002, 9: 71-84.
55. McLoon, L.K., Wirtschafter, J.D. Activated satellite cells in extraocular muscles of normal, adult monkeys and humans. Invest Ophthalmol Vis Sci 2003, 44: 1927-32.
56. McLoon, L.K., Wirtschafter, J.D. Continuous myonuclear addition to single extraocular myofibers of uninjured adult rabbits. Muscle Nerve 2002, 25: 348-58.
57. McLoon, L.K., Wirtschafter, J.D. Activated satellite cells in the extraocular muscles of adult mice. Trans Am Soc Ophthalmol 2002, 100: 119-24.
58. McLoon, L.K., Rowe, J., Wirtschafter, J.D., McCormick, K.M. Continuous myofiber remodeling in uninjured extraocular myofibers: Myonuclear turnover and evidence for apoptosis. Muscle Nerve 2004, 29: 707-15.
59. McLoon, L.K., Christiansen, S.P. Increasing extraocular muscle strength with insulin-like growth factor II. Invest Ophthalmol Vis Sci 2003, 44: 3866-72.
60. Falkenberg, J.H., Iaizzo, P.A., McLoon, L.K. Physiological assessment of muscle strength in vitro after direct injection of doxorubicin into rabbit sternocleidomastoid muscle. Mov Disord 2001, 16: 683-92.
61. Chen, J., von Bartheld, C.S. Role of exogenous and endogenous trophic factors in the regulation of extraocular muscle strength during development. Invest Ophthalmol Vis Sci 2004, 45: 3538-45.
62. Gill, D.M., Pappenheimer, A.M. Structure-activity relationships in diphtheria toxin. J Biol Chem 1971, 246: 1492-5.
63. Li, B., Ramakrishnan, S. Recombinant hybrid toxin with dual enzymatic activities. J Biol Chem 1994, 269: 2652-8.
64. Olson, T.A., Mohanraj, D., Roy, S., Ramakrishnan, S. Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int J Cancer 1997, 73: 865-70.